Pre-Conference Cardiometabolic Tech Summit |
|
11:00 - 11:10 am |
Opening Remarks Chair: Anne L. Peters, MD |
11:10 - 11:30 am |
An Introduction to Big Data and Its Role in Cardiometabolic Health Eric D. Peterson, MD |
11:30 - 11:50 am |
When is Genetic Testing Useful in Cardiometabolic Medicine |
12:05 - 1:05 pm |
PME Lunch Symposium Reviewing A1C and Cardiovascular Safety Data in T2D Therapies Sponsored by Novo Nordisk. |
1:20 - 2:05 pm |
Real-World Evidence in Cardiometabolic Health |
2:05 - 2:15 pm |
Expert Panel Discussion and Q & A Moderator: Anne L. Peters, MD Panel: Eric D. Peterson, MD; Elizabeth M. McNally, MD, PhD; Lawrence Blonde, MD |
2:15 - 2:25 pm |
mini-break |
2:25 - 2:40 pm |
New Generation Engagement: The New Frontier |
2:40 - 3:10 pm |
Moving Beyond A1C: Diabetes Devices and Their Clinical Use |
3:10 - 3:40 pm |
Wearables and Digital Health in Arrhythmia Management: Where Are We Headed? |
3:40 - 4:00 pm |
Expert Panel Discussion and Q & A Moderator: Anne L. Peters, MD Panelists: Mintu Turakhia, MD; Patrick Wayte |
4:00 - 4:15 pm |
mini-break |
4:15 - 5:15 pm |
PME Light Bites Symposium Cardiovascular Patient Cases Eliot A. Brinton, MD Sponsored by Amgen, Inc. |
5:20 - 6:20 pm |
PME Light Bites Symposium (Non-CME) Expert Insights: Managing Cardiovascular Risk Based on a Landmark CV Outcomes Study Sponsored by Amarin Pharma Inc. |
6:30 - 7:30 pm |
PME Dinner Symposium (Non-CME) Jardiance® (empagliflozin) tablets: Data from the comprehensive clinical development program James H. O’Keefe, MD Sponsored by Boehringer-Ingelheim. |
Session I - Diabetes Management |
|
6:30 - 7:45 am |
CME Breakfast Symposium A Chair: George L. Bakris, MD Faculty: Rajiv Agarwal, MD; Ileana L. Piña, MD, MPH Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc. |
7:55 - 8:00 am |
Opening Remarks |
8:00 - 9:30 am |
FDA Update and Late Breaking Trials Chair: Christie M. Ballantyne, MD Presenters: Deepak L. Bhatt, MD, MPH; Robert H. Eckel, MD; Keith C. Ferdinand, MD; Jay S. Skyler, MD |
9:30 - 10:15 am |
Keynote GLP-1 agonists: investigating the pleiotropic effects for cardio renal protection;What are the potential mechanisms involved? |
10:15 - 11:15 am |
Morning Break & Exhibits |
10:20 - 11:10 am |
Workshop 1 |
11:15 am - 12:05 pm |
Lifestyle Interventions for Prevention of Diabetes and the Metabolic Syndrome Edward S. Horton, MD |
12:20 - 1:35 pm |
CME Lunch Symposium A Reducing Cardiovascular Risk: A Paradigm Shift in T2DM Management Chair: Robert H. Eckel, MD Faculty: Lawrence Blonde; Tracy Y. Wang, MD Supported by an educational grant from Novo Nordisk. |
12:20 - 1:35 pm |
CME Lunch Symposium B |
1:45 - 2:25 pm |
Navigating Insulin Management in Patients with T2DM |
2:25 - 3:25 pm |
Afternoon Break & Exhibits |
2:30 - 3:15 pm |
Workshop 2 |
3:25 - 4:05 pm |
What to Choose? Initial Combination Therapy versus Sequential Therapy Julio Rosenstock, MD |
3:25 - 4:05 pm |
Workshop 3 |
4:05 - 5:20 pm |
Multidisciplinary Case Consults in Diabetes Management Chair: Jay S. Skyler, MD |
4:10 - 5:00 pm |
Workshop 4 Navigating the Prior Authorization Process |
5:25 - 6:25 pm |
Welcome Reception |
6:30 - 7:30 pm |
PME Dinner Symposium Understanding the Clinical Implications of Heart Failure and Renal Dysfunction in Your Patients With Type 2 Diabetes Sponsored by AstraZeneca |
Session II - Lipid Management |
|
6:30 - 7:45 am |
CME Breakfast Symposium A The Potassium Dilemma in HF and CKD: Challenges and Advancements in the Management of Hyperkalemia Chair: George L. Bakris, MD Faculty: Peter A. McCullough, MD, MPH; Biff F. Palmer, MD; Matthew R. Weir, MD Multi-supported by educational grants from AstraZeneca and Relypsa, Inc. |
7:55 - 8:00 am |
Opening Remarks |
8:00 - 8:30 am |
Guidelines and Gaps in Lipid Management |
8:30 - 9:00 am |
Treatment of High-Risk Patients with CVD and Elevated TGs: REDUCE-IT and Beyond Supported by an educational grant from Amarin Pharma, Inc. |
9:00 - 10:00 am |
Challenging Lipid Management Cases: Addressing the Gaps Chair: Christie M. Ballantyne, MD |
9:10 - 9:50 am |
Workshop 5 |
10:00 - 11:00 am |
Morning Break & Exhibits |
10:05 - 10:45 am |
Workshop 6 |
11:00 - 11:20 am |
Updates in Lp(a) |
11:20 - 11:40 am |
Role of Genetic Risk Scores for the Prevention of Cardiometabolic Disease |
11:40 - 11:45 am |
Closing Remarks |
12:00 - 1:15 pm |
CME Lunch Symposium A Challenges and Advances in the Diagnosis and Management of Heart Failure with Preserved Ejection Fraction Chair: Mariell Jessup, MD, FAHA Faculty: Javed Butler, MD, MPH, MBA; Alanna A. Morris, MD; Ileana L. Piña, MD, MPH Multi-supported by educational grants from Abbott and Novartis Pharmaceuticals Corporation. |
12:00 - 1:15 pm |
CME Lunch Symposium B Advances in Iron Repletion Therapy: Addressing the Burden of Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life Chair: Peter A. McCullough, MD, MPH Faculty: Biykem Bozkurt, MD; Andy Y. Lee, MD; Gurushner Panjrath, MD Supported by an educational grant from American Regent. |
Session III - HTN/HF Management |
|
1:25 - 1:30 pm |
Opening Remarks |
1:30 - 2:15 pm |
Hypertension: Integrating the Guidelines and Addressing the Gaps Chair: George L. Bakris, MD |
2:15 - 3:15 pm |
Afternoon Break & Exhibits |
2:25 - 3:10 pm |
Workshop 7 |
3:15 - 3:55 pm |
SGLT2 Inhibitors and Renal Preservation |
3:55 - 4:25 pm |
Role of Metabolic Syndrome in HFpEF |
4:25 - 5:05 pm |
Updates in HF and T2DM |
4:30 - 5:10 pm |
Workshop 8 |
5:05 - 5:10 pm |
Closing Remarks |
5:20 - 6:20 pm |
Happy Hour |
6:30 - 7:15 pm |
PME Light Bites Symposium Understanding CKD in T2D: The Risks, Recognition, and Clinical Management Peter A. McCullough, MD, MPH; Luiza Caramori, MD Sponsored by Bayer. |
7:20 - 8:35 pm |
CME Dinner Symposium Managing LDL-C to Reduce ASCVD Risk: Recent Advancements and Strategies to Optimize Patient Outcomes Chair: Christie M. Ballantyne, MD Faculty: Leslie Cho, MD Multi-supported by educational grants from Sanofi US and Regeneron Pharmaceuticals and Esperion. |
Session IV - Obesity/Lifestyle Management |
|
7:15 - 7:50 am |
Breakfast |
7:55 - 8:00 am |
Opening Remarks |
8:00 - 8:45 am |
Nutrition Beats Attrition: The Low Hanging Fruit for Cardiometabolic Health Stephen Devries, MD |
8:45 - 9:15 am |
Updates on Leptin and Obesity |
9:15 - 9:45 am |
Mechanism for Benefit of Metabolic Surgery |
9:45 - 10:15 am |
Lifestyle Approaches to Weight Reduction - Challenges Before Us |
10:15 - 10:25 am |
mini-break |
10:25 - 11:05 am |
Mechanisms of Obesity and Hypertension |
11:05 - 11:45 am |
NASH in a Dash |
11:45 am - 12:45 pm |
Multidisciplinary Case Consults in Obesity/Lifestyle Chair: Robert H. Eckel, MD |
12:45 - 12:50 pm |
Closing Remarks |
Pre-Conference Cardiometabolic Tech Summit |
|
11:00 - 11:10 am |
Opening Remarks Chair: Anne L. Peters, MD |
11:10 - 11:30 am |
An Introduction to Big Data and Its Role in Cardiometabolic Health Eric D. Peterson, MD |
11:30 - 11:50 am |
When is Genetic Testing Useful in Cardiometabolic Medicine |
1:20 - 2:05 pm |
Real-World Evidence in Cardiometabolic Health |
2:05 - 2:15 pm |
Expert Panel Discussion and Q & A Moderator: Anne L. Peters, MD Panel: Eric D. Peterson, MD; Elizabeth M. McNally, MD, PhD; Lawrence Blonde, MD |
2:25 - 2:40 pm |
New Generation Engagement: The New Frontier |
2:40 - 3:10 pm |
Moving Beyond A1C: Diabetes Devices and Their Clinical Use |
3:10 - 3:40 pm |
Wearables and Digital Health in Arrhythmia Management: Where Are We Headed? |
3:40 - 4:00 pm |
Expert Panel Discussion and Q & A Moderator: Anne L. Peters, MD Panelists: Mintu Turakhia, MD; Patrick Wayte |
4:05 - 5:20 pm |
Multidisciplinary Case Consults in Diabetes Management Chair: Jay S. Skyler, MD |
9:00 - 10:00 am |
Challenging Lipid Management Cases: Addressing the Gaps Chair: Christie M. Ballantyne, MD |
11:45 am - 12:45 pm |
Multidisciplinary Case Consults in Obesity/Lifestyle Chair: Robert H. Eckel, MD |
6:30 - 7:45 am |
CME Breakfast Symposium A Chair: George L. Bakris, MD Faculty: Rajiv Agarwal, MD; Ileana L. Piña, MD, MPH Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc. |
12:20 - 1:35 pm |
CME Lunch Symposium A Reducing Cardiovascular Risk: A Paradigm Shift in T2DM Management Chair: Robert H. Eckel, MD Faculty: Lawrence Blonde; Tracy Y. Wang, MD Supported by an educational grant from Novo Nordisk. |
12:20 - 1:35 pm |
CME Lunch Symposium B |
6:30 - 7:45 am |
CME Breakfast Symposium A The Potassium Dilemma in HF and CKD: Challenges and Advancements in the Management of Hyperkalemia Chair: George L. Bakris, MD Faculty: Peter A. McCullough, MD, MPH; Biff F. Palmer, MD; Matthew R. Weir, MD Supported by an educational grant from AstraZeneca and Relypsa, Inc. |
12:00 - 1:15 pm |
CME Lunch Symposium A Challenges and Advances in the Diagnosis and Management of Heart Failure with Preserved Ejection Fraction Chair: Mariell Jessup, MD, FAHA Faculty: Javed Butler, MD, MPH, MBA; Alanna A. Morris, MD; Ileana L. Piña, MD, MPH Multi-supported by educational grants from Abbott and Novartis Pharmaceuticals Corporation. |
12:00 - 1:15 pm |
CME Lunch Symposium B Advances in Iron Repletion Therapy: Addressing the Burden of Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life Chair: Peter A. McCullough, MD, MPH Faculty: Biykem Bozkurt, MD; Andy Y. Lee, MD; Gurushner Panjrath, MD Supported by an educational grant from American Regent. |
7:20 - 8:35 pm |
CME Dinner Symposium Managing LDL-C to Reduce ASCVD Risk: Recent Advancements and Strategies to Optimize Patient Outcomes Chaired by: Christie M. Ballantyne, MD Faculty: Leslie Cho, MD Multi-supported by educational grants from Sanofi US and Regeneron Pharmaceuticals and Esperion. |
10:15 - 11:15 am |
Morning Break & Exhibits |
2:25 - 3:25 pm |
Afternoon Break & Exhibits |
5:25 - 6:25 pm |
Welcome Reception |
10:00 - 11:00 am |
Morning Break & Exhibits |
2:15 - 3:15 pm |
Afternoon Break & Exhibits |
5:20 - 6:20 pm |
Happy Hour |
Session I - Diabetes Management |
|
7:55 - 8:00 am |
Opening Remarks |
11:15 am - 12:05 pm |
Lifestyle Interventions for Prevention of Diabetes and the Metabolic Syndrome |
1:45 - 2:25 pm |
Navigating Insulin Management in Patients with T2DM |
3:25 - 4:05 pm |
What to Choose? Initial Combination Therapy versus Sequential Therapy Julio Rosenstock, MD |
4:05 - 5:20 pm |
Multidisciplinary Case Consults in Diabetes Management Chair: Jay S. Skyler, MD |
Session II - Lipid Management |
|
7:55 - 8:00 am |
Opening Remarks |
8:00 - 8:30 am |
Guidelines and Gaps in Lipid Management |
8:30 - 9:00 am |
Treatment of High-Risk Patients with CVD and Elevated TGs: REDUCE-IT and Beyond Supported by an educational grant from Amarin Pharma, Inc. |
9:00 - 10:00 am |
Challenging Lipid Management Cases: Addressing the Gaps Chair: Christie M. Ballantyne, MD |
11:00 - 11:20 am |
Updates in Lp(a) |
11:20 - 11:40 am |
Role of Genetic Risk Scores for the Prevention of Cardiometabolic Disease |
11:40 - 11:45 am |
Closing Remarks |
Session III - HTN/HF Management |
|
1:25 - 1:30 pm |
Opening Remarks |
1:30 - 2:15 pm |
Hypertension: Integrating the Guidelines and Addressing the Gaps Chair: George L. Bakris, MD |
3:15 - 3:55 pm |
SGLT2 Inhibitors and Renal Preservation |
3:55 - 4:25 pm |
Role of Metabolic Syndrome in HFpEF |
4:25 - 5:05 pm |
Updates in HF and T2DM |
5:05 - 5:10 pm |
Closing Remarks |
Session IV - Obesity/Lifestyle Management |
|
7:55 - 8:00 am |
Opening Remarks |
8:00 - 8:45 am |
Nutrition Beats Attrition: The Low Hanging Friut for Cardiometabolic Health Stephen Devries, MD |
8:45 - 9:15 am |
Updates on Leptin and Obesity |
9:15 - 9:45 am |
Mechanism for Benefit of Metabolic Surgery |
9:45 - 10:15 am |
Lifestyle Approaches to Weight Reduction - Challenges Before Us |
10:25 - 11:05 am |
Mechanisms of Obesity and Hypertension |
11:05 - 11:45 am |
NASH in a Dash |
11:45 am - 12:45 pm |
Multidisciplinary Case Consults in Obesity/Lifestyle Chair: Robert H. Eckel, MD |
12:45 - 12:50 pm |
Closing Remarks |
9:30 - 10:15 am |
Keynote GLP-1 agonists: investigating the pleiotropic effects for cardio renal protection;What are the potential mechanisms involved? |
8:00 - 9:30 am |
FDA Update and Late Breaking Trials Chair: Christie M. Ballantyne, MD Presenters: Deepak L. Bhatt, MD, MPH; Robert H. Eckel, MD; Keith C. Ferdinand, MD; Jay S. Skyler, MD |
12:05 - 1:05 pm |
PME Lunch Symposium Reviewing A1C and Cardiovascular Safety Data in T2D Therapies Sponsored by Novo Nordisk. |
4:15 - 5:15 pm |
PME Light Bites Symposium Cardiovascular Patient Cases Eliot A. Brinton, MD Sponsored by Amgen, Inc. |
5:20 - 6:20 pm |
PME Light Bites Symposium (Non-CME) Expert Insights: Managing Cardiovascular Risk Based on a Landmark CV Outcomes Study Sponsored by Amarin Pharma Inc. |
6:30 - 7:30 pm |
PME Dinner Symposium (Non-CME) Jardiance® (empagliflozin) tablets: Data from the comprehensive clinical development program James H. O’Keefe, MD Sponsored by Boehringer-Ingelheim. |
6:30 - 7:30 pm |
PME Dinner Symposium Understanding the Clinical Implications of Heart Failure and Renal Dysfunction in Your Patients With Type 2 Diabetes Sponsored by AstraZeneca |
6:30 - 7:15 pm |
PME Light Bites Symposium Understanding CKD in T2D: The Risks, Recognition, and Clinical Management Peter A. McCullough, MD, MPH; Luiza Caramori, MD Sponsored by Bayer. |
5:25 - 6:25 pm |
Welcome Reception |
5:20 - 6:20 pm |
Happy Hour |
10:20 - 11:10 am |
Workshop 1 |
2:30 - 3:15 pm |
Workshop 2 |
3:25 - 4:05 pm |
Workshop 3 |
4:10 - 5:00 pm |
Workshop 4 Navigating the Prior Authorization Process |
9:10 - 9:50 am |
Workshop 5 |
10:05 - 10:45 am |
Workshop 6 |
2:25 - 3:10 pm |
Workshop 7 |
4:30 - 5:10 pm |
Workshop 8 |
Pre-Conference Cardiometabolic Tech Summit |
|
11:00 - 11:10 am |
Opening Remarks Chair: Anne L. Peters, MD |
11:10 - 11:30 am |
An Introduction to Big Data and Its Role in Cardiometabolic Health Eric D. Peterson, MD |
11:30 - 11:50 am |
When is Genetic Testing Useful in Cardiometabolic Medicine Elizabeth M. McNally, MD |
1:20 - 2:05 pm |
Real-World Evidence in Cardiometabolic Health |
2:05 - 2:15 pm |
Expert Panel Discussion and Q & A Moderator: Anne L. Peters, MD Panel: Eric D. Peterson, MD; Elizabeth M. McNally, MD, PhD; Lawrence Blonde, MD |
2:25 - 2:40 pm |
New Generation Engagement: The New Frontier |
2:40 - 3:10 pm |
Moving Beyond A1C: Diabetes Devices and Their Clinical Use |
3:10 - 3:40 pm |
Wearables and Digital Health in Arrhythmia Management: Where Are We Headed? |
3:40 - 4:00 pm |
Expert Panel Discussion and Q & A Moderator: Anne L. Peters, MD Panelists: Mintu Turakhia, MD; Patrick Wayte |
Session I - Diabetes Management |
|
6:30 - 7:45 am |
CME Breakfast Symposium A Chair: George L. Bakris, MD Faculty: Rajiv Agarwal, MD; Ileana L. Piña, MD, MPH Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc. |
7:55 - 8:00 am |
Opening Remarks |
9:30 - 10:15 am |
Keynote GLP-1 agonists: investigating the pleiotropic effects for cardio renal protection;What are the potential mechanisms involved? |
10:20 - 11:10 am |
Workshop 1 |
11:15 am - 12:05 pm |
Lifestyle Interventions for Prevention of Diabetes and the Metabolic Syndrome |
12:20 - 1:35 pm |
CME Lunch Symposium A Reducing Cardiovascular Risk: A Paradigm Shift in T2DM Management Chair: Robert H. Eckel, MD Faculty: Lawrence Blonde; Tracy Y. Wang, MD Supported by an educational grant from Novo Nordisk. |
1:45 - 2:25 pm |
Navigating Insulin Management in Patients with T2DM |
2:30 - 3:15 pm |
Workshop 2 |
3:25 - 4:05 pm |
What to Choose? Initial Combination Therapy versus Sequential Therapy Julio Rosenstock, MD |
4:05 - 5:20 pm |
Multidisciplinary Case Consults in Diabetes Management Chair: Jay S. Skyler, MD |
4:10 - 5:00 pm |
Workshop 4 Navigating the Prior Authorization Process |
6:30 - 7:45 am |
CME Breakfast Symposium A The Potassium Dilemma in HF and CKD: Challenges and Advancements in the Management of Hyperkalemia Chair: George L. Bakris, MD Faculty: Peter A. McCullough, MD, MPH; Biff F. Palmer, MD; Matthew R. Weir, MD Supported by an educational grant from AstraZeneca and Relypsa, Inc. |
12:00 - 1:15 pm |
CME Lunch Symposium A Challenges and Advances in the Diagnosis and Management of Heart Failure with Preserved Ejection Fraction Chair: Mariell Jessup, MD, FAHA Faculty: Javed Butler, MD, MPH, MBA; Alanna A. Morris, MD; Ileana L. Piña, MD, MPH Multi-supported by educational grants from Abbott and Novartis Pharmaceuticals Corporation. |
12:00 - 1:15 pm |
CME Lunch Symposium B Advances in Iron Repletion Therapy: Addressing the Burden of Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life Chair: Peter A. McCullough, MD, MPH Faculty: Biykem Bozkurt, MD; Andy Y. Lee, MD; Gurushner Panjrath, MD Supported by an educational grant from American Regent. |
Session III - HTN/HF Management |
|
1:25 - 1:30 pm |
Opening Remarks |
1:30 - 2:15 pm |
Hypertension: Integrating the Guidelines and Addressing the Gaps Chair: George L. Bakris, MD |
2:25 - 3:10 pm |
Workshop 6 |
3:15 - 3:55 pm |
SGLT2 Inhibitors and Renal Preservation |
3:55 - 4:25 pm |
Role of Metabolic Syndrome in HFpEF |
4:25 - 5:05 pm |
Updates in HF and T2DM |
4:30 - 5:10 pm |
Workshop 8 |
5:05 - 5:10 pm |
Closing Remarks |
Session II - Lipid Management |
|
7:55 - 8:00 am |
Opening Remarks |
8:00 - 8:30 am |
Guidelines and Gaps in Lipid Management |
8:30 - 9:00 am |
Treatment of High-Risk Patients with CVD and Elevated TGs: REDUCE-IT and Beyond |
9:00 - 10:00 am |
Challenging Lipid Management Cases: Addressing the Gaps Chair: Christie M. Ballantyne, MD |
9:10 - 9:50 am |
Workshop 5 |
10:05 - 10:45 am |
Workshop 6 |
11:00 - 11:20 am |
Updates in Lp(a) |
11:20 - 11:40 am |
Role of Genetic Risk Scores for the Prevention of Cardiometabolic Disease |
11:40 - 11:45 am |
Closing Remarks |
Session IV - Obesity/Lifestyle Management |
|
7:55 - 8:00 am |
Opening Remarks |
8:00 - 8:45 am |
Nutrition Beats Attrition: The Low Hanging Fruit for Cardiometabolic Health Stephen Devries, MD |
8:45 - 9:15 am |
Updates on Leptin and Obesity |
9:15 - 9:45 am |
Mechanism for Benefit of Metabolic Surgery |
9:45 - 10:15 am |
Lifestyle Approaches to Weight Reduction - Challenges Before Us |
10:25 - 11:05 am |
Mechanisms of Obesity and Hypertension |
11:05 - 11:45 am |
NASH in a Dash |
11:45 am - 12:45 pm |
Multidisciplinary Case Consults in Obesity/Lifestyle Chair: Robert H. Eckel, MD |
12:45 - 12:50 pm |
Closing Remarks |